ECON · BIO

Late Pharma, Early Bio

Reading Basel's architecture as a real-time signal of pharma's peak: Roche's last towers, the rising biotech cluster, the closed-loop labs replacing both.

Gordon J. Köhn
Cover image for Late Pharma, Early Bio

More local and more qualitative than usual: reading the City of Basel for the architecture of peaks. Institutions keep their monumental form long after the function moves on — hungry institutions build sheds; mature ones build statements.

Roche's towers, the Schällemätteli biotech cluster, and the horizontal Novartis Campus: three readings of the same moment in the same city. The bet isn't that big pharma ends — it's that the way scale gets built changes, towards closed-loop bio labs and targeted search across many smaller sites.

Roche Bau 1 and Bau 2 in Basel

Roche Bau 1 + Bau 2. Risograph-style derivative of a photograph by Michielverbeek (Wikimedia Commons), CC BY-SA 4.0. Click to read the full essay on Substack.


Read on Substack: Late Pharma, Early Bio